The initial rise in GIP secretion during OGTT correlates with the initial suppression of glucagon secretion in adolescents with obesity and type 2 diabetes

被引：0
|
作者：
Kristinsson, H. [1 ]
Manell, H. [1 ]
Dahlbom, M. [2 ]
Presto, J. [3 ]
Garedal, C. [3 ]
Ritzen, H. [3 ]
Vilhelmsson, M. [3 ]
Kilstedt, E. [3 ]
Johnson, F. [3 ]
Stenberg, H. [3 ]
Forslund, A. [2 ]
Bergsten, P. [1 ]
机构：
[1] Uppsala Univ, Uppsala, Sweden
[2] Akad Sjukhuset, Uppsala, Sweden
[3] Mercodia, Uppsala, Sweden
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
505
引用
收藏
页码：S247 / S247
页数：1
相关论文
共 50 条
  • [1] Metabolic Effects on Incretin and Glucagon Secretion in Obesity and Type 2 Diabetes
    Weber, Katharina S.
    Strassburger, Klaus
    Pacini, Giovanni
    Fritsch, Maria
    Bierwagen, Alessandra
    Hwang, Jong Hee
    Szendroedi, Julia
    Muessig, Karsten
    Roden, Michael
    [J]. DIABETES, 2017, 66 : A533 - A533
  • [2] Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
    Manell, Hannes
    Staaf, Johan
    Manukyan, Levon
    Kristinsson, Hjalti
    Cen, Jing
    Stenlid, Rasmus
    Ciba, Iris
    Forslund, Anders
    Bergsten, Peter
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (03): : 1181 - 1189
  • [3] Lack of suppression of glucagon during OGTT contributes to the reduced incretin effect in type 2 diabetes
    Knop, F. K.
    Vilsboll, T.
    Madsbad, S.
    Holst, J. J.
    Krarup, T.
    [J]. DIABETOLOGIA, 2006, 49 : 403 - 403
  • [4] Plasma Insulin Secretion Pattern during an OGTT Was Predictor of the Risk of Type 2 Diabetes
    Hayashi, Tomoshige
    Boyko, Edward J.
    McNeely, Marguerite J.
    Leonetti, Donna L.
    Kahn, Steven E.
    Fujimoto, Wilfred Y.
    [J]. DIABETES, 2009, 58 : A77 - A77
  • [5] The role of dysregulated glucagon secretion in type 2 diabetes
    D'Alessio, D.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 : 126 - 132
  • [6] Late Phase Insulin Resistance and Secretion during the OGTT Independently Predict the Risk of Type 2 Diabetes
    Hayashi, Tomoshige
    Boyko, Edward J.
    Sato, Kyoko Kogawa
    Mcneely, Marguerite J.
    Leonetti, Donna L.
    Kahn, Steven E.
    Fujimoto, Wilfred Y.
    [J]. DIABETES, 2011, 60 : A373 - A373
  • [7] The Separate and Combined Impact of the Intestinal Hormones, GIP, GLP-1 and GLP-2, on Glucagon Secretion in Type 2 Diabetes
    Lund, Asger
    Vilsb'Oll, Tina
    Bagger, Jonatan Issing
    Holst, Jens Juul
    Knop, Filip Krag
    [J]. DIABETES, 2010, 59 : A75 - A75
  • [8] The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
    Lund, Asger
    Vilsboll, Tina
    Bagger, Jonatan I.
    Holst, Jens J.
    Knop, Filip K.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (06): : E1038 - E1046
  • [9] The separate and combined impact of the intestinal hormones GIP, GLP-1 and GLP-2 on glucagon secretion in type 2 diabetes
    Lund, A.
    Vilsboll, T.
    Bagger, J. I.
    Holst, J. J.
    Knop, F. K.
    [J]. DIABETOLOGIA, 2010, 53
  • [10] Insulin secretion behaviour in Type 2 diabetes and abdominal obesity
    Hussein, S
    Popa, AR
    Albu, MS
    [J]. DIABETOLOGIA, 2001, 44 : A138 - A138
12345